Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0910
0.00 (0.00%)
Dec 3, 2025, 9:30 AM EST
Ayala Pharmaceuticals Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $5.11 million as of December 5, 2025. Its market cap has decreased by -80.26% in one year.
Market Cap
5.11M
Enterprise Value
n/a
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has decreased from 9.68M to 5.11M, a decrease of -47.22%. That is a compound annual growth rate of -25.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 5.11M | 283.70% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |